✦ LIBER ✦

S5-01-04: Can CSF biomarkers predict AD?

✍ Scribed by Tuula Pirttilä

Book ID: 118462434
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 50 KB
Volume: 2
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2006.05.352

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S5-01-02: Clinical criteria of AD—can we

S5-01-02: Clinical criteria of AD—can we make a diagnosis earlier

✍ Pieter Jelle Visser 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Can CSF biomarkers or pre-treatment prog

Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?

✍ Å. K. Wallin; O. Hansson; K. Blennow; E. Londos; L. Minthon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract ## Objective The main objective of this study was to investigate possible predictors of response to cholinesterase inhibitor (ChEI) treatment, including pre‐treatment progression rates and levels of the cerebrospinal fluid (CSF) biomarkers. A secondary objective was to evaluate whether

S4-01-04: Abeta-antibodies in serum and

S4-01-04: Abeta-antibodies in serum and CSF as potential marker of biological activity in AD

✍ Yansheng Du; Xing Wei; Liming Zhao; Richard Dodel; Harald Hampel; Martin Farlow 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

The relationship between cerebral spinal

The relationship between cerebral spinal fluid (CSF) biomarkers and Pittsburgh Compound B (PiB) positron emission tomography (PET) in predicting Alzheimer's disease (AD)

✍ Leah Burns; Robert Berman; Zhenchao Guo; Holly Soares; Stephen Kaplita; Bongin Y 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 92 KB